We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 908

Washington Healthcare Update - Jan 22, 2018
  • McGuireWoods LLP
  • USA
  • January 22 2018

The House passed a spending measure that funds the government until the middle of February. The bill includes a six-year extension of CHIP, a

OIG Report Highlights Impact of Improper Drug Classification
  • Arent Fox LLP
  • USA
  • January 12 2018

In late December 2017, the Office of Inspector General (OIG) of the Department of Health and Human Services (HHS) released the findings of a report

OIG Report Assesses Accuracy of Manufacturer-Reported Medicaid Rebate Program Data
  • Reed Smith LLP
  • USA
  • December 21 2017

The OIG recently issued a report evaluating the accuracy of pharmaceutical manufacturer-reported Medicaid drug rebate program data, including pricing

The State AG Report Weekly Update December 14, 2017
  • Cozen O'Connor
  • USA
  • December 14 2017

Republican state Representative Todd Atwater has declared his candidacy for South Carolina AG in 201

Washington Healthcare Update - Dec 4, 2017
  • McGuireWoods LLP
  • USA
  • December 4 2017

Testifying before the House Energy and Commerce Committee on implementation of the 21st Century Cures Act on Nov. 30, FDA Commissioner Scott Gottlieb

FDA Improving Regulatory Oversight of Stem Cell Therapies and Regenerative Medicine Products
  • Haynes and Boone LLP
  • USA
  • November 8 2017

Regenerative medicine is a burgeoning interdisciplinary research field aiming to offer new therapies that replace or regenerate human cells, tissues

CMS Revises Medicare Part B Biosimilar Coding and Payment Policies
  • Covington & Burling LLP
  • USA
  • November 8 2017

On November 1 and 2, 2017, the Centers for Medicare & Medicaid Services ("CMS") released two final rules addressing changes to Medicare Part B

OIG Releases October Work Plan Items; Includes Opioid REMS and Specialty Drug Coverage and Medicare Reimbursement
  • Cooley LLP
  • USA
  • October 17 2017

As we recently announced, the Office of Inspector General (OIG) is updating its Work Plan monthly rather than its previous twice-yearly publications

America’s Opioid Epidemic: Who Will Be Held Accountable?
  • Husch Blackwell LLP
  • USA
  • October 11 2017

In recent years America has seen an increasing number of opioid-involved deaths and is currently experiencing what the Center for Disease Control

Washington Healthcare Update - Aug 14, 2017
  • McGuireWoods LLP
  • USA
  • August 14 2017

Thirty-one Democratic Senators have written CMS Administrator Seema Verma urging her to drop a proposed rule that would require prospective patients